Brooks Labs incorporates wholly owned subsidiary Abridge Speciality Ltd
BROOKS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Brooks Laboratories has incorporated a wholly owned subsidiary named Abridge Speciality Limited on 2 July 2026. Brooks Labs will hold 100 percent of the new entity, which has an authorised share capital of Rs 1 lakh. The subsidiary belongs to the pharmaceutical manufacturing and marketing sector and has not yet started business operations. The move is aimed at supporting the company's strategic business expansion plans. No cash consideration details were disclosed beyond the initial face value subscription.
Minor capacity-building step; subsidiary is not operational yet, so limited immediate financial impact on shareholders.